Shanghai Rongtai Health Technology Corporation Limited (SHSE:603579) announces a share repurchase program. Under the program, the company will repurchase up to CNY 100 million worth of its RMB ordinary shares (A shares). The shares will be repurchases at a price of CNY 34.51 per share. The share repurchases will be funded from company's own funds. The purpose of share repurchases is to convert corporate bonds issued by the company that can be converted into stocks and for equity incentives. The program is valid for 12 months.

On June 25, 2021, the company announced that after the implementation of the annual equity distribution in 2020, the price ceiling for the repurchase of shares has been adjusted from CNY 35 per share to CNY 34.51 per share.